Filing Details

Accession Number:
0001140361-13-035602
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-11 09:58:51
Reporting Period:
2013-09-09
Filing Date:
2013-09-11
Accepted Time:
2013-09-11 09:58:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274826 Robert Baffi C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-09 20,000 $21.51 82,262 No 4 M Direct
Common Stock Disposition 2013-09-09 20,000 $73.00 62,262 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2013-09-09 20,000 $0.00 20,000 $21.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,351 2010-11-12 2020-05-11 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 4, 2013.
  2. Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th day of every month thereafter.
  3. Reflexts number of sock options outstanding after the transactionn from this specific sotck option grant.